Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-06-2020 | Case report

Vismodegib

Various toxicities: 17 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Wong C, et al. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series. Journal of the American Academy of Dermatology 82: 1539-1542, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1016/j.jaad.2020.02.050 Wong C, et al. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series. Journal of the American Academy of Dermatology 82: 1539-1542, No. 6, Jun 2020. Available from: URL: http://​doi.​org/​10.​1016/​j.​jaad.​2020.​02.​050
Metadata
Title
Vismodegib
Various toxicities: 17 case reports
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80017-7

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Imatinib

Case report

Bicalutamide

Case report

Multiple drugs

Case report

Entecavir